• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim

ABPI_Incentivising_Antibioics_peter-pryharski-unsplash_landscape
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Insight
11 min read 4th May 2022

Accounting for Preference Heterogeneity in Discrete Choice Experiments

A new publication co-authored by OHE’s David Mott provides an overview of the state of practice for accounting for preference heterogeneity in discrete choice experiments. The publication, which was a collaboration between members of the ISPOR Health Preference Research Special…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Choices_Brian-Jackson_AdobeStock_137193688-e1673972063160

A new publication co-authored by OHE’s David Mott provides an overview of the state of practice for accounting for preference heterogeneity in discrete choice experiments. The publication, which was a collaboration between members of the ISPOR Health Preference Research Special Interest Group, reports the results of a literature review and an expert survey.

What are discrete choice experiments (DCEs)?

DCEs are a stated preference method that can be used to elicit people’s preferences for a wide range of different topics by examining the trade-offs that they are willing to make. In health, DCEs have been used to explore a wide range of different questions (Soekhai et al., 2019). For example, OHE researchers have recently used the method to explore how people with experience of infertility value different aspects of Assistive Reproductive Therapy (Skedgel et al., 2021). Another OHE-led study compared the preferences of adults and adolescents for different EQ-5D-Y health states (Mott et al., 2021). OHE researchers also have an ongoing study with the Acute Leukemia Advocates Network to explore the preferences of people with acute leukaemia for different treatment characteristics.

What is preference heterogeneity?

Put simply, preference heterogeneity means that peoples’ preferences differ. Baseline models used to analyse DCE data actually assume the opposite – that preferences do not differ between respondents – which is unrealistic. It is therefore important for researchers to capture preference heterogeneity in their analyses to avoid biased results. An important distinction here is the difference between explained and unexplained heterogeneity. Explained heterogeneity is where preferences differ by some observable characteristics, such as the age or gender of respondents. An examination of explained heterogeneity can be an important aspect of a preference study – as noted in the recently published recommendations of the IMI PREFER project. In contrast, unexplained heterogeneity is not explained by observable characteristics. The methods for accounting for each type of heterogeneity differ.

How has preference heterogeneity been accounted for in practice?

The literature review found that many health preference studies have attempted to account for explained or unexplained preference heterogeneity, and that attempts to account for it appear to have increased over time. The former has involved the inclusion of interaction terms in models, whereas the latter has involved the use of more complex modelling approaches, such as latent class and mixed logit models. However, the expert survey indicated that health preference researchers are concerned about the rising complexity of models, and that there is some confusion and disagreement around the best approaches to use.

What were the implications of the study?

Preference heterogeneity was widely deemed important to account for, and many researchers have done so in practice. However, it was also felt that more pragmatic guidance would be beneficial to assist health preference researchers in future.

The manuscript was published in Value in Health and can be found here.

If you’d like to find out more about DCEs and how they could be used to address your research questions, please get in touch with Chris Skedgel or David Mott.

 

Citation

Vass, C., Boeri, M., Karim, S., Marshall, D., Craig, B., Ho, K.-A., Mott, D. J., Ngorsuraches, S., Badawy, S. M., Mühlbacher, A., Gonzalez, J. M., & Heidenreich, S. (2022). Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group Report. Value in Health, 25(5), 685–694.

Related research

Mott, D. J. (2018). Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind? The Patient, 11(3), 249–252.

Mott, D. J., Chami, N., & Tervonen, T. (2020). Reporting Quality of Marginal Rates of Substitution in Discrete Choice Experiments That Elicit Patient Preferences. Value in Health, 23(8), 979–984.

Mott, D. J., Hampson, G., Llewelyn, M. J., Mestre-Ferrandiz, J., & Hopkins, M. M. (2020). A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance. Applied Health Economics and Health Policy, 18(1), 69–79.

Skedgel, C., Wailoo, A., & Akehurst, R. (2015). Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment. Medical Decision Making, 35(1), 94–105.

  • Research
  • Measuring and Valuing Outcomes
  • External Publications

Related Insights

HealthData&Stats_AdobeStock_168196575_landscape
  • Insight
  • August 2022

Improving the Measurement of Valued Output in Primary Care in England

Read more
Good and Broken Light Bulb
  • Insight
  • July 2022

Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly

Read more
NHSFinance_Adobe_ink-drop-scaled-1
  • Insight
  • June 2022

The State of Play for Cost-effectiveness Thresholds

Read more
Sleepio_Adobe_montblanca-e1673970227875
  • Insight
  • May 2022

Sleepio: Lessons from the Frontier of Digital Therapeutics

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!